Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AACR, albeit, alphabetical, Alto, ASCT, Britain, CA, Chair, channel, CI, CIMA, commodity, Crimea, CTD, Cullinan, Donetsk, Eryspase, exacerbate, expend, France, geopolitical, GPCR, Gustave, Helen, HEOR, hoc, HRU, Ignacio, immunomodulator, Inline, INSERM, insight, IQVIA, ITT, Jon, lifetime, Luhansk, magnify, Marabelle, MDR, Melero, MHRA, Navarra, nuclear, Palo, pharmacoeconomic, PhD, purity, QALY, reconsider, Reg, Republic, Robert, Ronald, Roussy, SAB, separatist, Spain, speeding, Stanford, strongly, Summy, supposed, Today, Ukraine, USAN, variation, vendor, Wigginton, WTP
Removed:
adding, Africa, army, autumn, back, balixafortide, begun, belonging, Chinese, claw, commencing, defeat, deterioration, earliest, easier, effected, eliminated, facing, fighting, Foamix, freely, fundamentalist, gained, Gamida, Genentech, harvesting, iPharma, Iranian, Iraq, irrevocable, Islamic, ITA, location, mixed, nivolumab, North, offsetting, owed, Palestinian, Polyphor, quicker, ranging, realization, reverse, seed, sourced, Standstill, subordinated, summer, Syrian, TaiGen, tangible, turmoil, ulocuplumab, unconsolidated, undistributed, uniform, violence
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 4.16 Exhibit 4.16
- 4.19 Exhibit 4.19
- 4.20 Exhibit 4.20
- 4.22 Exhibit 4.22
- 4.23 Exhibit 4.23
- 4.24 Exhibit 4.24
- 8.1 Exhibit 8.1
- 12.1 Certification of the Chief Executive Officer Under Section 302 of
- 12.2 Certification of the Chief Financial Officer Under Section 302 of
- 13.1 Certification of Chief Executive Officer Under Section 906 of
- 13.2 Certification of Chief Financial Officer Under Section 906 of
- 15.1 Exhibit 15.1
- Download Excel data file
- View Excel data file
Associated BLRX transcripts
BLRX similar filings
Filing view
External links
Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-176419, 333-183976, 333-201326 and 333-208865) and Form F-3 (No. 333-251857 and 333-229021) of BioLineRx Ltd. of our report dated March 15, 2022 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F.
Tel-Aviv, Israel | /s/ Kesselman & Kesselman |
March 15, 2022 | Certified Public Accountants (Isr.) |
A member firm of PricewaterhouseCoopers International Limited |